1. Home
  2. OBDC vs ALKS Comparison

OBDC vs ALKS Comparison

Compare OBDC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Owl Capital Corporation

OBDC

Blue Owl Capital Corporation

HOLD

Current Price

$11.35

Market Cap

5.3B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.88

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBDC
ALKS
Founded
2015
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.5B
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
OBDC
ALKS
Price
$11.35
$33.88
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$14.28
$43.43
AVG Volume (30 Days)
5.6M
2.7M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
13.81%
N/A
EPS Growth
N/A
N/A
EPS
1.24
1.43
Revenue
N/A
$1,475,899,000.00
Revenue This Year
N/A
$24.26
Revenue Next Year
N/A
$4.63
P/E Ratio
$8.80
$23.60
Revenue Growth
N/A
N/A
52 Week Low
$10.52
$25.17
52 Week High
$15.19
$36.48

Technical Indicators

Market Signals
Indicator
OBDC
ALKS
Relative Strength Index (RSI) 55.50 59.47
Support Level $11.07 $26.80
Resistance Level $11.69 $35.46
Average True Range (ATR) 0.32 1.41
MACD 0.04 0.28
Stochastic Oscillator 90.76 67.14

Price Performance

Historical Comparison
OBDC
ALKS

About OBDC Blue Owl Capital Corporation

Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: